
Welcome to this month’s ADVOCATE BRIEF
March Momentum: Driving Policy, Equity & Accountability Forward
As we turn the page to April, we reflect on March’s most pressing healthcare stories. From regulatory debates and cost transparency to community trust in clinical research, we’re bringing insights that impact advocacy, policy, and innovation. This month, healthcare headlines were dominated by policy shifts surrounding Medicaid funding and work requirements, ongoing scrutiny of pharmacy benefit managers, and renewed federal interest in healthcare price transparency. In parallel, discussions on health equity and patient engagement gained momentum, underscoring the urgency to address systemic gaps in access and trust. Amidst these changes, Archo Advocacy remains committed to keeping you informed, empowered, and equipped to drive meaningful impact. Let’s explore what shaped the healthcare landscape last month—and what it means for patients and advocates going forward.
POLICY PULSE: POLITICAL
Where Legislation Meets the Lives of Patients…
Key Insights:
Medicaid Work Requirements: Cost-Cutting or Barrier to Access?: House Republicans revive proposals for work requirements in Medicaid eligibility. Proponents say it’s about reducing spending; critics warn it may worsen inequity.
Congressional Spotlight on Biosimilar Market Reform: A look into payer negotiations and Congressional interest in biosimilar competition reveals a push toward cost containment and greater regulation.
👉 Share your thoughts: How should Medicaid balance cost control with care equity?
Coming up: We shift from Capitol Hill to your wallet—how insurers, pharmacies, and hospital systems are shaping the cost of care at the ground level.
COST OF CARE: ECONOMIC
Affordability, Access, and the Dollars in Between…
Behind every policy lies a price tag—and behind every patient story, the struggle to afford care. From payer influence to pharmacy closures, economic forces are reshaping access and driving healthcare inequities. This section dives into where dollars are flowing—and where barriers are building.
Key Insights:
BCBSA Targets Hospital and Pharma Cost Drivers: A new proposal from the Blue Cross Blue Shield Association outlines aggressive reforms to address rising healthcare costs, including transparency from middlemen.
Major Retail Pharmacies Cut Hours Nationwide: CVS, Walgreens, and Walmart trim pharmacy hours amid staffing shortages and economic headwinds—raising access concerns for patients. If it’s bad for them, then the current environment is terrible for neighborhood pharmacies who are often underpaid by the large PBM/Payer conglomerates.
👉 Question for readers: How do pharmacy closures affect patient care in your community?
Next, we zoom in on the lived experience—how access, trust, and representation shape outcomes at the community level.

Continuing to Help You Engage With Your Customers With Vital Market Intelligence
COMMUNITY LENS: SOCIOCULTURAL
Centering the Patient Voice in Systems of Care
Equity in healthcare goes beyond coverage—it’s about trust, dignity, and inclusion. As the nation emerges from pandemic-era protections, millions are left behind in Medicaid rollbacks. Simultaneously, persistent gaps in clinical trial trust continue to undermine participation among historically marginalized communities.
Key Insights:
Clinical Trials and the Trust Gap in Black Communities: Findings from the Lupus Goal Cohort highlight a disconnect between Black patients and clinical research, emphasizing the need for representation and trust-building.
Medicaid Enrollment Plummets Post-COVID: Millions lose coverage as eligibility redeterminations restart—most affected are low-income and minority populations, raising equity concerns.
👉 Join the conversation: Has your organization (or how have you) seen a shift in Medicaid-covered populations?
Up next: From AI at the bedside to cyberattacks on hospital systems—how tech is changing the game in real-time.
TECH TRENDS: TECHNOLOGY
Disruption Meets Diagnosis: The Digital Health Wave
Whether it’s generative AI helping clinicians or ransomware halting hospital operations, technology is transforming every corner of healthcare. This month’s tech insights reveal promise and peril—highlighting the need for innovation, readiness, and digital literacy. Patients and Advocacy organizations continue to battle for a voice to keep a seat at the table for the patient voice to ensure large language models and AI do not replace them. However, there are valuable spaces for AI in patient navigation and identification through analyzing patient insights via the electronic medical records within the health system.
Epic Integrates ChatGPT into EHRs: AI comes to the bedside. Epic’s partnership with OpenAI enables providers to use generative AI for clinical notes, patient summaries, and more.
Ransomware Attack Hits Health Systems Hard: A widespread cyberattack disables IT infrastructure at several hospitals, underscoring growing vulnerabilities in digital healthcare systems.
👉 Explore more: Is your health system prepared for AI and cybersecurity threats?
Let’s close out with a few final reflections and an invitation to engage further with our community of advocates.
Final Thoughts & Call To Action: Get Involved!
Information is power in a healthcare system undergoing seismic shifts, and collaboration is the engine of progress. As you reflect on this month’s stories, we invite you to stay curious, stay connected, and continue pushing for systems that center on patients and communities.
📣 Join the Conversation: Follow Archo Advocacy on LinkedIn for real-time insights into health equity, affordability, and advocacy. You can also join our LinkedIn group here: https://www.linkedin.com/groups/14492481/
📣 Forward this brief to a colleague who needs to see it.
📝White Paper Option 1: Check out our white papers on the value of Patient Advocacy function in BRIDGING THE GAP: Unlocking the Power of Patient Advocacy: A Strategic Imperative for Biotech, Pharma & CROs - https://archo.io/ebook/
📝White Paper Option 2: You can also gather insights from the industry’s first benchmarking of the patient advocacy function in pharma, biotech and medical device companies in our white paper BRIDGING THE GAP: MAXIMIZING PATIENT ENGAGEMENT: A Data-Driven Evaluation of the Patient Advocacy Function - https://elavayreport.com/bioadvocate-benchmark/
1 All references can be found here: https://docs.google.com/spreadsheets/d/1DN8QyfRGTCwNOypwUr-a8exTPTiCLh4HzgVhtB_6OOQ/edit?pli=1&gid=1096875129#gid=1096875129
